在肝衰竭高风险群体中预测血流感染 具有人工肝支持系统的患者
Alternative therapies in health and medicine
|June 28, 2024
概括
这项研究开发了一种名谱,用于预测人工肝支持肝脏衰竭患者的血流细菌感染. 该模型准确地识别了关键的风险因素,改善了患者的治疗结果.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 传染性疾病 传染性疾病
- 医疗技术 医疗技术 医学技术
背景情况:
- 肝衰竭是一种具有高死亡率的严重疾病,通常由血液中的细菌感染复杂化.
- 人工肝脏支持系统,特别是血交换,是使用的,但感染风险需要更好的预测.
- 了解这些患者感染的风险因素对于及时干预至关重要.
研究的目的:
- 预测血液中的细菌感染高风险肝衰竭患者接受人造肝支持.
- 识别和验证这一脆弱患者群体中感染的关键预测因素.
- 开发一种风险评估的视觉预测工具.
主要方法:
- 一项前性队列研究,涉及118名肝衰竭患者,接受以血交换为中心的人工肝支持.
- 逐步二元物流回归被用来确定感染的最佳风险因素.
- 为可视化和预测血流感染而构建了一个名ogram预后模型.
主要成果:
- 在118名患者中,有22名患者 (18.64%) 患有血流细菌感染.
- 有意义的预测因素包括培养水平,糖皮质激素的使用,穿刺,血小板计数,白细胞计数和导管停留时间.
- 诺米图表显示出高预测准确度,AUC为0.935,灵敏度为0.955,特异性为0.854.
结论:
- 一个经过验证的nomogram预后模型可以有效地识别人工肝支持肝功能衰竭患者血流感染的风险因素.
- 这种工具有助于准确的预测,使得有针对性的预防策略和改进的患者管理.
- 该模型的高精度支持其在人工肝支持治疗期间管理感染风险的临床实用性.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
882
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
882
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
382
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271


